BACKGROUND: Although epidemiological studies have demonstrated an increased predisposition to low high-density lipoprotein cholesterol and high triglyceride levels in the Mexican population, Mexicans have not been included in any of the previously reported genome-wide association studies for lipids. METHODS AND RESULTS: We investigated 6 single-nucleotide polymorphisms associated with triglycerides, 7 with high-density lipoprotein cholesterol, and 1 with both triglycerides and high-density lipoprotein cholesterol in recent Caucasian genome-wide association studies in Mexican familial combined hyperlipidemia families and hypertriglyceridemia case-control study samples. These variants were within or near the genes ABCA1, ANGPTL3, APOA5, APOB, CETP, GALNT2, GCKR, LCAT, LIPC, LPL (2), MMAB-MVK, TRIB1, and XKR6-AMAC1L2. We performed a combined analysis of the family-based and case-control studies (n=2298) using the Z method to combine statistics. Ten of the single-nucleotide polymorphisms were nominally significant and 5 were significant after Bonferroni correction (P=2.20 x 10(-3) to 2.6 x 10(-11)) for the number of tests performed (APOA5, CETP, GCKR, and GALNT2). Interestingly, our strongest signal was obtained for triglycerides with the minor allele of rs964184 (P=2.6 x 10(-11)) in the APOA1/C3/A4/A5 gene cluster region that is significantly more common in Mexicans (27%) than in whites (12%). CONCLUSIONS: It is important to confirm whether known loci have a consistent effect across ethnic groups. We show replication of 5 Caucasian genome-wide association studies lipid associations in Mexicans. The remaining loci will require a comprehensive investigation to exclude or verify their significance in Mexicans. We also demonstrate that rs964184 has a large effect (odds ratio, 1.74) and is more frequent in the Mexican population, and thus it may contribute to the high predisposition to dyslipidemias in Mexicans.
BACKGROUND: Although epidemiological studies have demonstrated an increased predisposition to low high-density lipoprotein cholesterol and high triglyceride levels in the Mexican population, Mexicans have not been included in any of the previously reported genome-wide association studies for lipids. METHODS AND RESULTS: We investigated 6 single-nucleotide polymorphisms associated with triglycerides, 7 with high-density lipoprotein cholesterol, and 1 with both triglycerides and high-density lipoprotein cholesterol in recent Caucasian genome-wide association studies in Mexican familial combined hyperlipidemia families and hypertriglyceridemia case-control study samples. These variants were within or near the genes ABCA1, ANGPTL3, APOA5, APOB, CETP, GALNT2, GCKR, LCAT, LIPC, LPL (2), MMAB-MVK, TRIB1, and XKR6-AMAC1L2. We performed a combined analysis of the family-based and case-control studies (n=2298) using the Z method to combine statistics. Ten of the single-nucleotide polymorphisms were nominally significant and 5 were significant after Bonferroni correction (P=2.20 x 10(-3) to 2.6 x 10(-11)) for the number of tests performed (APOA5, CETP, GCKR, and GALNT2). Interestingly, our strongest signal was obtained for triglycerides with the minor allele of rs964184 (P=2.6 x 10(-11)) in the APOA1/C3/A4/A5 gene cluster region that is significantly more common in Mexicans (27%) than in whites (12%). CONCLUSIONS: It is important to confirm whether known loci have a consistent effect across ethnic groups. We show replication of 5 Caucasian genome-wide association studies lipid associations in Mexicans. The remaining loci will require a comprehensive investigation to exclude or verify their significance in Mexicans. We also demonstrate that rs964184 has a large effect (odds ratio, 1.74) and is more frequent in the Mexican population, and thus it may contribute to the high predisposition to dyslipidemias in Mexicans.
Authors: Z Galcheva-Gargova; L Gangwani; K N Konstantinov; M Mikrut; S J Theroux; T Enoch; R J Davis Journal: Mol Biol Cell Date: 1998-10 Impact factor: 4.138
Authors: J J Genest; S S Martin-Munley; J R McNamara; J M Ordovas; J Jenner; R H Myers; S R Silberman; P W Wilson; D N Salem; E J Schaefer Journal: Circulation Date: 1992-06 Impact factor: 29.690
Authors: Martijn C G J Brouwers; Marleen M J van Greevenbroek; Coen D A Stehouwer; Jacqueline de Graaf; Anton F H Stalenhoef Journal: Nat Rev Endocrinol Date: 2012-02-14 Impact factor: 43.330
Authors: Jacqueline M Major; Kai Yu; Charles C Chung; Stephanie J Weinstein; Meredith Yeager; William Wheeler; Kirk Snyder; Margaret E Wright; Jarmo Virtamo; Stephen Chanock; Demetrius Albanes Journal: J Nutr Date: 2012-03-21 Impact factor: 4.798
Authors: Mark Bi; Wen Hong Linda Kao; Eric Boerwinkle; Ron C Hoogeveen; Laura J Rasmussen-Torvik; Brad C Astor; Kari E North; Josef Coresh; Anna Köttgen Journal: PLoS One Date: 2010-07-22 Impact factor: 3.240
Authors: Tamara S Roman; Amanda F Marvelle; Marie P Fogarty; Swarooparani Vadlamudi; Arlene J Gonzalez; Martin L Buchkovich; Jeroen R Huyghe; Christian Fuchsberger; Anne U Jackson; Ying Wu; Mete Civelek; Aldons J Lusis; Kyle J Gaulton; Praveen Sethupathy; Antti J Kangas; Pasi Soininen; Mika Ala-Korpela; Johanna Kuusisto; Francis S Collins; Markku Laakso; Michael Boehnke; Karen L Mohlke Journal: Am J Hum Genet Date: 2015-12-03 Impact factor: 11.025